No change in testosterone, androstenedione, sex-hormone binding globulin among premenopausal or postmenopausal women
THURSDAY, Oct. 27, 2022 (HealthDay News) — Sex steroid levels remain largely unchanged with short-term time-restricted eating (TRE) among women, according to a study published online Oct. 6 in Obesity.
Faiza Kalam, Ph.D., from Northwestern University in Chicago, and colleagues conducted a secondary analysis of an eight-week TRE study conducted in adults with obesity. After exclusion of men and perimenopausal women, the remaining women were classified as premenopausal or postmenopausal (12 and 11, respectively).
The researchers found that body weight decreased in premenopausal and postmenopausal women (−3 ± 2 percent and −4 ± 2 percent, respectively) after eight weeks, with no difference observed between the groups. No change was seen in circulating levels of testosterone, androstenedione, or sex hormone-binding globulin in either group. In premenopausal and postmenopausal women, decreases were seen in dehydroepiandrosterone concentrations (−14 ± 32 percent and −13 ± 34 percent, respectively), with no difference observed between the groups. No changes were seen in estradiol, estrone, or progesterone, which were only measured in postmenopausal women.
“This secondary analysis suggests that short-term TRE, which produces minimal weight loss (3 to 4 percent), has little effect on sex steroid levels in premenopausal or postmenopausal females with obesity,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Most Metabolic and Bariatric Surgery Candidates Meet Criteria for Clinical Obesity
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk